Table 10.6b

Immunosuppression Use for Induction by Discharge Regimen, 2000 to 2004

Recipients with Intestine Transplants

  Discharge Regimen (w/ or w/o Steroids Use) All
CyA Tac Tac+ MMF Tac+ Aza Tac+ Siro Other
Functioning Graft with Immunosuppression Info at Discharge 1 327 36 6 69 26 465
% of All Regimens 0.2% 70.3% 7.7% 1.3% 14.8% 5.6% 100.0%
Induction Drug 0.0% 0.0% 5.6% 0.0% 1.4% 19.2% 1.7%
Atgam/NRATG/NRATS
OKT3 0.0% 2.8% 2.8% 0.0% 0.0% 26.9% 3.7%
Thymoglobulin 0.0% 27.8% 11.1% 0.0% 13.0% 88.5% 27.3%
Zenapax 0.0% 11.0% 55.6% 100.0% 33.3% 107.7% 24.3%
Simulect 0.0% 2.8% 5.6% 0.0% 34.8% 26.9% 9.0%
Campath 0.0% 9.5% 5.6% 0.0% 0.0% 19.2% 8.2%
No Induction Drugs Recorded 100.0% 46.8% 19.4% 0.0% 17.4% 15.4% 38.1%


Source: OPTN/SRTR Data as of May 2, 2005.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.